Seif , Hwang & Pierangeli Management of the antiphospholipid syndrome : new approaches Review

@inproceedings{Seif2009SeifH,
  title={Seif , Hwang & Pierangeli Management of the antiphospholipid syndrome : new approaches Review},
  author={Alan M Seif and Yong Sik Hwang and Silvia S. Pierangeli},
  year={2009}
}
Antiphospholipid syndrome (APS) is an autoimmune and multisystem disorder of thrombosis and pregnancy loss, associated with the persistent presence of antiphospholipid (aPL) antibodies [1–3]. These antibodies are directed against protein antigens that bind to anionic phospholipids, such as b 2 glycoprotein I (b 2 GPI) and prothrombin. Thrombosis is the major manifestation in patients with APS, but the spectrum of symptoms and signs associated with aPL antibodies has considerably broadened, and… CONTINUE READING

References

Publications referenced by this paper.
SHOWING 1-10 OF 118 REFERENCES

Genomics and proteomics: a new approach for assessing thrombosis risk in autoimmune diseases

C López-Pedrera, N Barbarroka, +3 authors MJ Cuadrado
  • Lupus 17,
  • 2008